Table 3.

Median public sector procurement prices and median patient prices, in local currency and as price ratios to median prices in the four-comparator countries

		Public Sector Procurement Price			Private Sector Patient Pricea
No.	Medicine Name	Median Price (Mex$)	MPR (LATAMc)	MPR (MSH)	Median Price (Mex$)	MPR (LATAMc)
1	Anastrozole 1 mg tab	24.29	2.12	2.35	47.36	1.27
2	Bevacizumab 100 mg inj	53.58	0.58		102.59	0.82
3	Bevacizumab 400 mg inj	48.67	0.66		92.48	0.84
4	Capecitabine 500 mg tab	22.07	0.59	0.67	73.33	0.89
5	Carboplatin 150 mg inj	1.27	0.31	0.65	2.67	0.21
6	Cetuximab 5 mg/ml inj	40.81	0.61		77.43	1.01
7	Cyclophosphamide 200 mg inj	0.15	0.41	0.36	0.21	0.35
8	Cyclophosphamide 500 mg inj	0.14	0.37	0.45	0.20	0.42
9	Cytarabine 500 mg inj	0.30	1.08	1.66	0.60	0.58
10	Dasatinib 50 mg tab	573.78	0.57		1132.27	1.46
11	Daunorubicin 20 mg inj	5.90	0.25	0.31	12.99	0.31
12	Docetaxel 20 mg/1 ml inj	62.93	3.40	12.42	99.53	0.54
13	Docetaxel 80 mg/4 ml inj	51.83	5.56	12.08	82.00	2.48
14	Doxorubicin 10 mg inj	7.45	1.23	1.79	17.53	0.42
15	Doxorubicin 50 mg inj	3.92	0.86	1.38	9.20	0.49
16	Epirubicin 10 mg/5 ml inj	12.84	0.36	1.20	34.35	0.59
17	Epirubicin 50 mg/25 ml inj	6.20	0.41	0.73	21.28	0.38
18	Etoposide 20 mg/ml inj	0.49	0.64	1.30	1.06	2.01
19	Everolimus 10 mg tab	1702.00	0.83		2414.97	0.65
20	Everolimus 5 mg tab	425.50	0.44		1207.48	0.65
21	Exemestane 25 mg tab	69.18	1.08	1.69	58.50	0.66
22	Fluorouracil 250 mg inj	0.08	0.49	0.38	0.13	0.63
23	Folinic Acid 50 mg/4 ml inj	3.56	0.76	3.88	4.60	1.14
24	Folinic Acid 15 mg tab	15.84	0.71	0.62	23.33	0.80
25	Gemcitabine 1 g inj	0.44	0.32	0.89	1.95	0.37
26	Ifosfamide 1 g inj	0.27	0.75	1.30	0.63	0.83
27	Imatinib 100 mg tab	57.32	0.54	4.22	281.58	0.52
28	Imatinib 400 mg tab	219.48	0.77	0.44	1192.74	0.66
29	Irinotecan 20 mg/ml inj	6.97	1.20	6.16	19.34	0.35
30	L-Asparaginase 10,000 IU inj	0.11	0.49	1.06	0.14	0.92
31	Letrozole 2.5 mg tab	2.62	0.04	0.28	35.00	1.03
32	Mercaptopurine 50 mg tab	33.24	0.59	0.76	54.48	1.25
33	Methotrexate 2.5 mg tab	1.20	0.36	0.39	5.81	1.73
34	Methotrexate 500 mg inj	0.45	1.13	1.35	0.79	0.61
35	Methotrexate 50 mg inj	1.22	0.59	0.59	3.44	1.05
36	Nilotinib 200 mg tab	279.07	0.56	11.92	579.59	0.84
37	Oxaliplatin 100 mg/20 ml inj	6.36	0.78	0.43	17.15	0.18
38	Oxaliplatin 50 mg/10 ml inj	8.52	1.11	0.75	17.45	0.13
39	Paclitaxel 6 mg/ml inj	2.78	0.76		8.72	0.58
40	Panitimumab 20 mg/ml inj	76.99	0.84		157.23	1.18
41	Pazopanib 200 mg tab	170.44	0.56		297.90	0.59
42	Pazopanib 400 mg tab	339.86	0.57		595.85	0.45
43	Rituximab 100 mg/10 ml inj	13.09	0.45	0.49	77.46	0.85
44	Rituximab 500 mg/50 ml inj	10.82	0.21	0.31	77.44	1.26
45	Sorafenib 200 mg tab	404.04	0.73		622.82	0.67
46	Sunitinib 12.5 mg tab	326.01	0.43		717.58	0.53
47	Tamoxifen 20 mg tab	1.46	0.68	0.66	4.90	0.41
48	Trastuzumab 440 mg inj	49.29	0.68		94.56	0.97
49	Vincristine 1 mg inj	53.66	0.36	0.84	101.00	0.53
	Median	12.84	0.59	0.80	41.18	0.65

OB originator brand, LPG lowest price generic, tab tablet, inj injectable, mg milligrams, ml milliliters, IU international unit, n number of facilities surveyed and included in the analysis, LATAMc Latin American countries, MPR median price ratio, Mex$ mexican peso, MSH management sciences for health

^aMedian prices and MPR in the private sector: we present only the median prices and the MPR of the lowest priced generic medicines. For medicines with no generic alternatives, we present the median prices and the MPR of the patented/originator medicine